DK166884D0 - Pyrimidinderivater - Google Patents

Pyrimidinderivater

Info

Publication number: DK166884D0
Authority: DK; Denmark
Prior art keywords: pyrimidine
Prior art date: 1983-03-25

Application number

DK1668/84A

Other languages

English (en)

Other versions

DK166884A (da

DK160492B (da

DK160492C (da

Inventor

Takao Takaya

Masayoshi Murata

Kiyotaka Ito

Original Assignee

Fujisawa Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-03-25

Filing date

1984-03-23

Publication date

1984-03-23

1983-03-25 Priority claimed from GB838308290A external-priority patent/GB8308290D0/en

1983-06-07 Priority claimed from GB838315542A external-priority patent/GB8315542D0/en

1983-10-18 Priority claimed from GB838327859A external-priority patent/GB8327859D0/en

1984-03-23 Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co

1984-03-23 Publication of DK166884D0 publication Critical patent/DK166884D0/da

1984-09-26 Publication of DK166884A publication Critical patent/DK166884A/da

1991-03-18 Publication of DK160492B publication Critical patent/DK160492B/da

1991-08-26 Application granted granted Critical

1991-08-26 Publication of DK160492C publication Critical patent/DK160492C/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/20—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D239/22—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Diabetes (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

DK166884A 1983-03-25 1984-03-23 Pyrimidinderivater, fremgangsmaader til fremstilling heraf samt farmaceutiske praeparater indeholdende disse derivater DK160492C (da)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
GB838308290A GB8308290D0 (en)	1983-03-25	1983-03-25	Pyrimidinone derivatives
GB8308290		1983-03-25
GB838315542A GB8315542D0 (en)	1983-06-07	1983-06-07	Pyrimidinone derivatives
GB8315542		1983-06-07
GB838327859A GB8327859D0 (en)	1983-10-18	1983-10-18	Pyrimidine derivatives
GB8327859		1983-10-18

Publications (4)

Publication Number	Publication Date
DK166884D0 true DK166884D0 (da)	1984-03-23
DK166884A DK166884A (da)	1984-09-26
DK160492B DK160492B (da)	1991-03-18
DK160492C DK160492C (da)	1991-08-26

Family

ID=27262023

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK166884A DK160492C (da)	1983-03-25	1984-03-23	Pyrimidinderivater, fremgangsmaader til fremstilling heraf samt farmaceutiske praeparater indeholdende disse derivater

Country Status (13)

Country	Link
US (3)	US4612376A (da)
EP (1)	EP0123402B1 (da)
KR (1)	KR840008333A (da)
CA (1)	CA1256107A (da)
DE (1)	DE3473875D1 (da)
DK (1)	DK160492C (da)
ES (2)	ES8505972A1 (da)
FI (1)	FI841128A7 (da)
GR (1)	GR81758B (da)
HU (1)	HU195195B (da)
NO (1)	NO841168L (da)
PH (1)	PH22022A (da)
SU (2)	SU1349698A3 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4612376A (en) *	1983-03-25	1986-09-16	Fujisawa Pharmaceutical Co., Ltd.	Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent
US4598149A (en) *	1984-03-02	1986-07-01	Merck & Co., Inc.	3-amino-2-hydroxypropyl of pyrimidin-4-one useful as antihypertensive, cardioprotective, antiarrythmic, and antianginal agents
US4649142A (en) *	1984-06-25	1987-03-10	Fujisawa Pharmaceutical Co., Ltd.	3,4-dihydro-1,3-disubstituted-6-(substituted phenylimino)-2(1H)-pyrimidinone useful as cardiotonic agent and anti-allergic agent
US4708958A (en) *	1986-09-24	1987-11-24	G. D. Searle & Co.	6-(imidazolyphenyl)-4-iminopyrimidinones useful as hypotensive agents
US5521315A (en) *	1993-01-12	1996-05-28	Cell Therapeutics, Inc.	Olefin substituted long chain compounds
IT1270122B (it) *	1994-10-04	1997-04-28	Ist Superiore Sanita	6-benzil-4-ossopirimidine sostituite, processo per la loro preparazione e composizioni farmaceutiche che le contengono
RU2170734C2 (ru) *	1995-09-06	2001-07-20	Кова Ко., Лтд.	Производные пиримидина, фармацевтическая композиция и способ профилактики и лечения болезни
US6244121B1 (en) *	1998-03-06	2001-06-12	Applied Materials, Inc.	Sensor device for non-intrusive diagnosis of a semiconductor processing system
CN102558155A (zh)	2003-01-14	2012-07-11	阿伦纳药品公司	作为代谢调节剂的芳基和杂芳基衍生物及其所涉及的疾病如糖尿病和高血糖症的预防和治疗
AU2004257267B2 (en)	2003-07-14	2009-12-03	Arena Pharmaceuticals,Inc	Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
DOP2006000009A (es)	2005-01-13	2006-08-15	Arena Pharm Inc	Procedimiento para preparar eteres de pirazolo [3,4-d] pirimidina
EP1924262B1 (en)	2005-08-22	2011-11-16	Melior Pharmaceuticals I, Inc.	Methods and formulations for modulating lyn kinase activity and treating related disorders
KR20100014480A (ko) *	2007-02-20	2010-02-10	멜리어 파마슈티칼스 아이, 인코포레이티드	Ｌｙｎ 키나제 활성제의 확인 방법
AU2008279242A1 (en) *	2007-07-23	2009-01-29	Melior Discovery, Inc.	Methods of activating IRS-1 and AKT
US8552184B2 (en) *	2008-07-03	2013-10-08	Melior Pharmaceuticals I, Inc.	Compounds and methods for treating disorders related to glucose metabolism
EP2462123B1 (en) *	2009-08-04	2013-10-02	Merck Sharp & Dohme Corp.	4,5,6-trisubstituted pyrimidine derivatives as factor ixa inhibitors
EP4148045A1 (en)	2010-01-27	2023-03-15	Arena Pharmaceuticals, Inc.	Intermediate compounds for the preparation of (r)-2-(7-(4-cyclopentyl-3- (trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b] indol-3-yl)acetic acid and salts thereof
US20130158055A1 (en)	2010-05-28	2013-06-20	Andrew G. Reaume	Prevention Of Pancreatic Beta Cell Degeneration
EA201390421A1 (ru)	2010-09-22	2013-09-30	Арена Фармасьютикалз, Инк.	Модуляторы рецептора gpr119 и лечение связанных с ним нарушений
JP6632532B2 (ja) *	2014-08-29	2020-01-22	国立大学法人東京大学	オートタキシン阻害活性を有するピリミジノン誘導体
US10183949B2 (en)	2014-08-29	2019-01-22	The University Of Tokyo	Pyrimidinone derivative having autotaxin-inhibitory activity
EP4445956A3 (en)	2015-01-06	2024-12-04	Arena Pharmaceuticals, Inc.	Compound for use in treating conditions related to the s1p1 receptor
PL3310760T3 (pl)	2015-06-22	2023-03-06	Arena Pharmaceuticals, Inc.	Krystaliczna sól L-argininy kwasu (R)-2-(7-(4-cyklopentylo-3-(trifluorometylo)benzyloksy)- 1,2,3,4-tetrahydrocyklo-penta[b]indol-3-ilo)octowego do zastosowania w zaburzeniach związanych z receptorem S1P1
CN110520124A (zh)	2017-02-16	2019-11-29	艾尼纳制药公司	用于治疗原发性胆汁性胆管炎的化合物和方法
KR102634575B1 (ko)	2017-04-10	2024-02-06	멜리어 파마슈티칼스 아이, 인코포레이티드	지방세포의 처리
CA3102136A1 (en)	2018-06-06	2019-12-12	Arena Pharmaceuticals, Inc.	Methods of treating conditions related to the s1p1 receptor
CN109053589A (zh) *	2018-09-30	2018-12-21	浙江师范大学	4-亚胺基四氢嘧啶-2-酮类化合物的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1296371A (da) *	1969-02-26	1972-11-15
AU1108070A (en) *	1969-03-06	1971-08-12	Imperial Chemical Industries Limited	Pyrimidine derivatives
GB1336138A (en) *	1969-12-10	1973-11-07	Ici Ltd	Process for the production of pyrimidine derivatives
US3923807A (en) *	1973-09-10	1975-12-02	Takeda Chemical Industries Ltd	6-Aminouracil derivatives
US4208366A (en) *	1978-10-31	1980-06-17	E. I. Du Pont De Nemours And Company	Process for preparing a nonwoven web
DE2847693A1 (de) *	1978-11-03	1980-05-22	Hoechst Ag	Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen
US4612376A (en) *	1983-03-25	1986-09-16	Fujisawa Pharmaceutical Co., Ltd.	Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent

1984
- 1984-03-12 US US06/588,902 patent/US4612376A/en not_active Expired - Fee Related
- 1984-03-14 EP EP84301741A patent/EP0123402B1/en not_active Expired
- 1984-03-14 PH PH30400A patent/PH22022A/en unknown
- 1984-03-14 GR GR74104A patent/GR81758B/el unknown
- 1984-03-14 DE DE8484301741T patent/DE3473875D1/de not_active Expired
- 1984-03-20 KR KR1019840001414A patent/KR840008333A/ko not_active Ceased
- 1984-03-21 FI FI841128A patent/FI841128A7/fi not_active Application Discontinuation
- 1984-03-21 CA CA000450076A patent/CA1256107A/en not_active Expired
- 1984-03-23 HU HU841170A patent/HU195195B/hu not_active IP Right Cessation
- 1984-03-23 DK DK166884A patent/DK160492C/da active IP Right Grant
- 1984-03-23 ES ES530916A patent/ES8505972A1/es not_active Expired
- 1984-03-23 NO NO841168A patent/NO841168L/no unknown
- 1984-03-23 SU SU843718401A patent/SU1349698A3/ru active
- 1984-11-30 ES ES538190A patent/ES538190A0/es active Granted
1985
- 1985-03-28 SU SU853892541A patent/SU1436872A3/ru active
1986
- 1986-06-05 US US06/870,826 patent/US4746664A/en not_active Expired - Fee Related
1988
- 1988-03-25 US US07/173,584 patent/US4824851A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
FI841128A0 (fi)	1984-03-21
DK166884A (da)	1984-09-26
KR840008333A (ko)	1984-12-14
PH22022A (en)	1988-05-13
SU1436872A3 (ru)	1988-11-07
FI841128A7 (fi)	1984-09-26
NO841168L (no)	1984-09-26
CA1256107A (en)	1989-06-20
DK160492B (da)	1991-03-18
EP0123402B1 (en)	1988-09-07
SU1349698A3 (ru)	1987-10-30
ES530916A0 (es)	1985-06-16
ES8505972A1 (es)	1985-06-16
GR81758B (da)	1984-12-12
EP0123402A2 (en)	1984-10-31
US4824851A (en)	1989-04-25
ES8601922A1 (es)	1985-11-01
EP0123402A3 (en)	1985-09-18
HU195195B (en)	1988-04-28
DE3473875D1 (en)	1988-10-13
ES538190A0 (es)	1985-11-01
US4746664A (en)	1988-05-24
US4612376A (en)	1986-09-16
DK160492C (da)	1991-08-26

Publication	Publication Date	Title
FI830256A0 (fi)	1983-01-26	Silplaot
NO845017L (no)	1985-06-17	Hoeyspennings-koplingsstykke
DK298784D0 (da)	1984-06-19	Kobber-leder-praeparater
DK166884D0 (da)	1984-03-23	Pyrimidinderivater
DK473184D0 (da)	1984-10-02	Azetidioner
BR8400003A (pt)	1984-07-31	Retroprojetor
DK327985D0 (da)	1985-07-18	Pyrimidinderivater
DE3480475D1 (de)	1989-12-21	5-heteroarylimidazol-2-ones
DK309084D0 (da)	1984-06-25	Aminopyrimidinderivater
DK310184A (da)	1984-12-28	Spirosuccinimider
DK198784D0 (da)	1984-04-17	Pyrimidonderivater
DE3463268D1 (de)	1987-05-27	3-oxaprostaglandins
DK586684D0 (da)	1984-12-07	Polymert biocid
DK153567C (da)	1988-12-05	Stabelbar petriskaal
ATA454783A (de)	1984-07-15	Lusterbehang
FI832452A0 (fi)	1983-07-04	Haollare
DK510484D0 (da)	1984-10-25	Substituerede pyrimidiner
DK96185A (da)	1985-03-29	Pattekopgriber
FI830202A0 (fi)	1983-01-21	Hugg
DK299285A (da)	1985-07-01	Formeanlaeg
AT385002B (de)	1988-02-10	Geraeuschgedaempftes schienenrad
ATA160983A (de)	1988-03-15	Beschlag
ATA312084A (de)	1990-07-15	Bandsaatschar
DD232186A5 (de)	1986-01-22	Schaedlingsbekaempfungsmittel
FI830555A0 (fi)	1983-02-18	Ljudisoleringselement

Legal Events

Date	Code	Title	Description
1992-11-23	PBP	Patent lapsed
1993-07-26	B1	Patent granted (law 1993)